Table 1.
Clinical information of patients.
|
AITL (n = 167) |
ALCL (n = 10) |
Other PTCLs (n = 20) |
MF (n = 6) |
Sesary (n = 1) |
ATLL (n = 1) |
HES (n = 3) |
T-CUS (n = 3) |
|
|---|---|---|---|---|---|---|---|---|
| Sample | 258 | 12 | 22 | 6 | 1 | 1 | 3 | 3 |
| BM | 151 | 4 | 20 | 4 | 1 | 1 | 3 | 3 |
| PB | 8 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tissue | 85 | 8 | 2 | 2 | 0 | 0 | 0 | 0 |
| Body fluid | 14 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Sex | ||||||||
| Male | 120 | 8 | 16 | 5 | 0 | 0 | 1 | 1 |
| Female | 47 | 2 | 4 | 1 | 1 | 1 | 2 | 2 |
| Age | ||||||||
| Age range | 19–82 | 7–70 | 32–83 | 51–63 | - | - | 4–56 | 58–83 |
| Median age | 59 | 33.5 | 54 | 57.5 | - | - | 39 | 67 |
BM, bone marrow; PB, peripheral blood; AITL, angioimmunoblastic T-cell lymphoma; ALCL, anaplastic large cell lymphoma; PTCL, peripheral T-cell lymphomas; MF, mycosis fungoides; ATLL, adult T-cell leukemia/lymphoma; L-HES, lymphocyte-variant hypereosinophilic syndrome; T-CUS, T-cell clones of uncertain clinical significance; “-,” absent.